fbpx
Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
lifestyle riskfactors brainhealth research Alzheimer's management

A Late-Stage Alzheimer’s Trial Gave Them Hope—Until It Was Canceled

By | March 22nd, 2019

Jeff Borghoff and his wife Kimberly speak about participating in the Biogen drug trial testing aducanumab, a drug that targets beta-amyloid. The late-stage trial was recently canceled, news that sent participants, their families, researchers and stocks reeling.

[ Next: ‘They Are Still Here, and They Can Still Contribute’: What He Learned From Alzheimer’s at Age 51 ]

Advertisement

One thought on “A Late-Stage Alzheimer’s Trial Gave Them Hope—Until It Was Canceled

Leave a Reply

Your email address will not be published. Required fields are marked *